Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582842 · ClinicalTrials.gov registry record
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,800
- Enrollment target
NCT00582842: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582842 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582842 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,800 participants
- Enrollment target
Study Summary
The purpose of this study is to assess quality-of-life of men with prostate cancer. "Quality-of-life" means how you feel about your life as a result of your disease and its treatment. The investigators hope that this questionnaire will help show how prostate cancer treatments affect quality-of-life. It will help doctors and future patients to make better treatment choices. Some men may wish to have a more demanding treatment with a higher risk of harmful effects. Others may prefer a treatment that will have the smallest effect on their quality-of-life. This questionnaire will help us measure these effects and decide which is the best treatment for a given patient.
Interventions
- BEHAVIORAL Interview
- BEHAVIORAL survey instruments using Web-Based Data Collection System (WBDC) survey content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,800 participants |
| Start Date | 2002-05-14 |
| Est. Completion | 2022-12-21 |
What the finished NCT00582842 record still lists
NCT00582842 is an observational study that tracks outcomes without assigning an intervention. Its 1,800 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Interview is the first listed.
NCT00582842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582842 about?
NCT00582842 is a clinical study titled "Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer". The purpose of this study is to assess quality-of-life of men with prostate cancer. "Quality-of-life" means how you feel about your life as a result of your disease and its treatment. The investigators hope that this questionnaire will help show how prostate cancer treatments affect quality-of-life....
What is the current status of trial NCT00582842?
This trial is currently completed. The enrollment target is 1,800 participants. The study started on 2002-05-14. Estimated completion is 2022-12-21.
What interventions are being tested in trial NCT00582842?
The interventions under investigation include: Interview (BEHAVIORAL), survey instruments using Web-Based Data Collection System (WBDC) survey content (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582842?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
- NCT04980794 · 1,800 participants · NA
The Happy Families Project: Testing the Effectiveness of a Conflict Resolution Program for Families
- NCT05258656 · 1,800 participants · NA
Childhood Activities Nutrition and Development Oversight
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI